Paxman AB (publ) announced that it has signed a letter of interest with a plan to enter in to a distribution and marketing agreement with Guangzhou Concord Medical Sci-Tech Innovation Center Co. Ltd. to jointly develop the market for the Paxman Scalp Cooling System within the Greater China territory, including Macau, Taiwan and Mongolia. The initial collaboration is for a period of five years and will include an evaluation period of 24 months to treat up to 300 patients at Concord Medical's Guangzhou Concord Cancer Center (GCCC), a National Health Commission certified tertiary specialty hospital, situated in Sino-Singapore Guangzhou Knowledge City.